Principal Financial Group’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-408
| Closed | -$7.96K | – | 2443 |
|
|
2024
Q1 | $7.96K | Sell |
408
-111
| -21% | -$2.17K | ﹤0.01% | 2421 |
|
|
2023
Q4 | $10.7K | Hold |
519
| – | – | ﹤0.01% | 2410 |
|
|
2023
Q3 | $16.5K | Buy |
519
+96
| +23% | +$3.05K | ﹤0.01% | 2424 |
|
|
2023
Q2 | $14.2K | Buy |
+423
| New | +$14.2K | ﹤0.01% | 2415 |
|
|
2022
Q4 | – | Sell |
-895
| Closed | -$44K | – | 2528 |
|
|
2022
Q3 | $44K | Sell |
895
-1,564
| -64% | -$76.9K | ﹤0.01% | 2415 |
|
|
2022
Q2 | $97K | Buy |
2,459
+762
| +45% | +$30.1K | ﹤0.01% | 2395 |
|
|
2022
Q1 | $63K | Sell |
1,697
-661
| -28% | -$24.5K | ﹤0.01% | 2475 |
|
|
2021
Q4 | $231K | Sell |
2,358
-2,921
| -55% | -$286K | ﹤0.01% | 2320 |
|
|
2021
Q3 | $659K | Sell |
5,279
-506
| -9% | -$63.2K | ﹤0.01% | 2099 |
|
|
2021
Q2 | $726K | Buy |
5,785
+2,601
| +82% | +$326K | ﹤0.01% | 2119 |
|
|
2021
Q1 | $432K | Buy |
3,184
+243
| +8% | +$33K | ﹤0.01% | 2194 |
|
|
2020
Q4 | $267K | Buy |
+2,941
| New | +$267K | ﹤0.01% | 2260 |
|